Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED BALANCE SHEETS

v3.24.3
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
Sep. 30, 2024
Dec. 31, 2023
Current assets:    
Cash $ 90 $ 65,222
Accounts receivable, net 0 740
Grant receivable 314,170 76,266
Prepaid expenses 38,837 44,891
Total current assets 353,097 187,119
Property and equipment, net 31,685 50,943
Right to use assets 208,709 97,278
Other assets:    
Patents, net 8,143 9,027
Deposits, long term 41,936 44,520
Total other assets 50,079 53,547
Total assets 643,570 388,887
Current liabilities:    
Accounts payable and accrued expenses, including related party payables of $1,292,381 and $1,683,453, respectively 5,681,787 4,649,179
Lease liability, short term 39,266 122,732
Derivative liability 0 53,460
Notes payable, net of debt discount of $20,790 and $354,730, respectively 1,288,290 606,750
Notes payable, related parties, net of debt discount of $0 and $77,295, respectively 1,214,982 999,088
Total current liabilities 8,224,325 6,431,209
Long term liabilities:    
Economic Injury Disaster loan, long term 71,393 72,466
Royalty obligation, net of discount of $4,540,472 and $4,899,354, related parties 4,181,628 3,822,746
Lease liability, long term 169,443 10,945
Deferred revenue, long term 0 4,045
Total liabilities 12,646,789 10,341,411
Preferred stock, no par value, 600,000 authorized    
Common stock, $0.001 par value; 750,000,000 shares authorized, 11,211,595 and 8,674,029 shares issued and outstanding as of September 30, 2024 and December 31, 2023, respectively 11,212 8,674
Common stock subscribed 100,000 100,009
Additional paid in capital 70,080,274 68,149,029
Accumulated deficit (82,044,527) (78,103,018)
Total deficit attributable to BioCorRx Inc. (11,831,425) (9,823,690)
Non-controlling interest (171,794) (128,834)
Total deficit (12,003,219) (9,952,524)
Total liabilities and deficit 643,570 388,887
Series A Convertible Preferred Stock [Member]    
Preferred stock, no par value, 600,000 authorized    
Preferred Stock Value 16,000 16,000
Series B Convertible Preferred Stock [Member]    
Preferred stock, no par value, 600,000 authorized    
Preferred Stock Value $ 5,616 $ 5,616